Mutations in DNMT3A and IDH1/2, genes that encode epigenetic modifiers, are present in the early pre‐leukaemic cells and these “founder” mutations can be implicated as functional components of AML evolution. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.